PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10667442

Measure for measure.

J D Bullock
View original source ↗Export metadata ↓

Abstract

Shakespeare's play Measure for Measure colorfully illustrates a concept that is relevant to the testimonies given by the medical expert witness in the courtroom. The expert should not ask the jury to hold the defendant physician to a higher standard than that actually practiced by an acceptable reasonable minority of the defendant's peers under similar circumstances. Two cases are presented.

Explore related subjects

Adenocarcinoma, SebaceousAgedExpert TestimonyEye InjuriesEyelid NeoplasmsFemaleHumansInfantMaleMalpracticeNeoplasm Recurrence, LocalOphthalmologic Surgical ProceduresOphthalmologyRetinal DetachmentSebaceous Gland NeoplasmsTime FactorsWounds, NonpenetratingCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J D Bullock. Measure for measure.. https://doi.org/10.1016/s0039-6257(99)00120-4

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Incidence of eyelid cancers in Taiwan: a 21-year review.

PURPOSE: To describe the epidemiologic characteristics and incidence trends of primary eyelid cancers in the Chinese population in Taiwan between 1979 and 1999. DESIGN: Retrospective population-based cancer registry data review. PARTICIPANTS: A total of 1166 primary eyelid cancers coded to International Classification of Diseases 8 or 9, site 172.1 (malignant melanoma of eyelid) and 173.1 (other malignant neoplasm of eyelid) were retrieved from the Taiwan National Cancer Registry between January 1979 and December 1999. Of these, 1121 (96.1%) were histopathologically verified and were used for analysis. METHODS: Age- and gender-specific incidence rates were calculated and were age-adjusted to the 2000 world standard population. Trends in incidence rates were estimated by calculating the annual percentage change. We further examined the effects of age, period of diagnosis, and birth cohort on incidence trends using age-period-cohort analysis. MAIN OUTCOME MEASURE: Age-standardized incidence rate. RESULTS: The mean age at diagnosis of eyelid cancers was 62.6+/-14.1 years. The average annual age-standardized incidence rate was 3.2 per million during the study period. There was an overall increase of incidence rates from 1.5 per million in 1979 to 5.1 per million in 1999, with an annual percentage change of 4.63% (P<0.001). The most common eyelid malignancy was basal cell carcinoma (BCC; 65.1%), followed by squamous cell carcinoma (12.6%), and sebaceous cell carcinoma (7.9%). The increasing rates were mainly driven by an increase in the incidence of BCC. Cohort effects were found to play a major role in terms of model fit for the incidence trends of BCC. CONCLUSIONS: These national data reveal a rapidly increasing incidence of eyelid cancers from 1979 to 1999 in Taiwan. Basal cell carcinoma dominates the incidence trends, and the significant cohort effects give a warning of increasing risk of BCC in younger birth cohorts.

Adenocarcinoma, Sebaceous↗
PubMed2006

Sebaceous carcinoma of the breast: case report and review of the literature.

Sebaceous differentiation has been described in only limited examples of benign and malignant epithelial lesions of the breast. We report a rare case of mammary sebaceous carcinoma to further delineate its morphologic features. Microscopically, the tumor, arising in the right mammary gland of a 63-year-old woman, was composed of well-defined solid sheets or lobules of atypical epithelial cells including many large pale or clear cells with often scalloped nuclei and coarsely vacuolated cytoplasm, in which abundant lipid droplets were identified with oil-red-O staining. Immunohistochemical expressions of cytokeratin, epithelial membrane antigen, and receptors of estrogen and progesterone were detected, whereas GCDFP-15, S-100 protein, vimentin, alpha-smooth muscle actin, p63, androgen receptor, and the HER2/neu protein were not expressed. Besides, a subset of the tumor cells co-expressed synaptophysin, neurofilament, and PGP9.5, suggesting neuroendocrine differentiation that is a hitherto undescribed phenomenon in the mammary tumors with sebaceous features. This case would expand the morphologic diversity of carcinoma of the breast.

Adenocarcinoma, Sebaceous↗